E. Yilmaz Et Al. , "Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?," NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.12, pp.1242-1249, 2020
Yilmaz, E. Et Al. 2020. Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?. NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.12 , 1242-1249.
Yilmaz, E., Engin, M. N., Oezkan, Z. G., Kovan, B., Bueyuekkaya, F., Poyanli, A., ... Saglam, S.(2020). Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?. NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.12, 1242-1249.
Yilmaz, Ebru Et Al. "Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?," NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.12, 1242-1249, 2020
Yilmaz, Ebru Et Al. "Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?." NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.12, pp.1242-1249, 2020
Yilmaz, E. Et Al. (2020) . "Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?." NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.12, pp.1242-1249.
@article{article, author={Ebru Yilmaz Et Al. }, title={Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2020, pages={1242-1249} }